Urolithiasis pp 553-556 | Cite as

Reliability of a Single 24-Hour Urine Testing for the Detection of Abnormal Stone-Forming Risk Factors

  • R. D. Brown
  • B. V. Adams
  • C. Y. C. Pak
  • G. M. Preminger

Abstract

There continues to be an important role for the medical evaluation and management of recurrent urolithiasis. Appropriate therapy depends upon identification of underlying physiologic or environmental defects which might account for the stone disease. Several protocols have been devised to investigate basic underlying metabolic and environmental abnormalities.

Keywords

Stone Formation Stone Disease Texas Southwestern Medical Urinary Citrate Urinary Stone Formation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    CYC Pak, F Britton, R Peterson, D Ward, C Northcutt, NA Breslau, J McGuire, K Sakhaee, S Bush, M Nicar, D Norman, and PV Peters, Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria, Am. J. Med. 69: 19 (1980).PubMedCrossRefGoogle Scholar
  2. 2.
    JR Burns and B Finlayson, Strategies for the medical management of patients with urinary stone disease, Monographs in Urol. 2: 4 (1981).Google Scholar
  3. 3.
    GM Preminger, JA Harvey, and CYC Pak, Comparative efficacy of “specific” potassium citrate therapy versus conservative management in nephrolithiasis of mild-moderate severity, J. Urol. 134: 658 (1985).PubMedGoogle Scholar
  4. 4.
    WG Drach, R Perin, and S Jacobs, Outpatient evaluation of patients with calcium nephrolithiasis, J. Urol. 121: 564 (1979).PubMedGoogle Scholar
  5. 5.
    GW Pitts and MI Resnick, Urinary stone formation-patient evaluation and management, Urol. Clin. North America 7: 45 (1979).Google Scholar
  6. 6.
    M Menon and CS Krishnan, Evaluation and medical management of the patient with calcium stone disease, Urol. Clin. North America 10: 595 (1983).Google Scholar
  7. 7.
    GM Preminger and CYC Pak, Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria, J. Urol. 137: 1104 (1987).PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • R. D. Brown
    • 1
  • B. V. Adams
    • 1
  • C. Y. C. Pak
    • 1
  • G. M. Preminger
    • 1
  1. 1.Center for Mineral Metabolism and Clinical Research, and Division of Urology, Department of SurgeryUniversity of Texas Southwestern Medical CenterDallasUSA

Personalised recommendations